Exploring Three High Growth Tech Stocks in Europe

The European market has recently faced challenges, with the STOXX Europe 600 Index declining and major indices like Germany’s DAX and France’s CAC 40 experiencing significant drops amid geopolitical tensions and economic uncertainties. In this environment, identifying high growth tech stocks requires a focus on companies that demonstrate resilience through innovation, robust demand for their products or services, and an ability to navigate complex market dynamics effectively.

Top 10 High Growth Tech Companies In Europe

Click here to see the full list of 60 stocks from our European High Growth Tech and AI Stocks screener.

Let’s uncover some gems from our specialized screener.

Simply Wall St Growth Rating: ★★★★★★

Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and sells injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK14.91 billion.

Operations: Bonesupport Holding AB generates revenue primarily from its pharmaceuticals segment, amounting to SEK1.22 billion. The company focuses on developing and selling injectable bio-ceramic bone graft substitutes internationally.

Bonesupport Holding, a European biotech firm, has demonstrated robust financial and operational growth. In the first quarter of 2026, the company’s sales rose to SEK 324.02 million from SEK 283.54 million in the previous year, complemented by a net income increase to SEK 53.38 million from SEK 10.43 million. This performance is underpinned by an impressive earnings growth rate of 51.3% over the past year, significantly outpacing the industry average of 45%. Moreover, their commitment to innovation is evident from their recent clinical advancements with CERAMENT G, which has shown promising results in treating high-risk open fractures without infections or reoperations at follow-up. This blend of strong financial results and innovative medical solutions positions Bonesupport well in a competitive biotech landscape.

OM:BONEX Earnings and Revenue Growth as at Apr 2026

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sectra AB (publ) is a company that offers solutions in medical IT and cybersecurity across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market capitalization of SEK50.75 billion.

Operations: Sectra generates revenue primarily through its Imaging IT Solutions segment, which accounts for SEK3 billion, followed by Secure Communications at SEK396.96 million, and Business Innovation at SEK105.86 million. The company’s operations focus on providing specialized solutions in medical IT and cybersecurity across several European countries.

Sectra, a European tech firm specializing in medical imaging IT and cybersecurity, has recently secured significant contracts that underscore its growth trajectory and innovation in cloud-based solutions. Notably, the company’s Sectra One Cloud service will be implemented across six NHS Trusts under a five-year contract valued at GBP 15.6 million, enhancing radiology and breast imaging capabilities with potential for further specialty expansion. This move not only solidifies Sectra’s presence in the UK healthcare sector but also reflects its strategic focus on scalable managed services that promise recurring revenue streams. Additionally, the adoption of Sectra’s Education Portal by all Norwegian health regions illustrates its commitment to advancing medical education through technology. These developments are pivotal as they align with Sectra’s R&D emphasis which saw an investment spike by 12% last year, fostering innovations like AI-driven diagnostic solutions showcased at HIMSS 2026.

OM:SECT B Earnings and Revenue Growth as at Apr 2026

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Shoper S.A. offers software as a service solutions for e-commerce in Poland, with a market cap of PLN1.13 billion.

Operations: Shoper S.A. generates revenue by providing e-commerce software solutions in Poland, focusing on a subscription-based model. The company emphasizes cost efficiency, which impacts its net profit margin trends over time.

Shoper S.A. continues to outpace the Polish market with a robust 13.4% annual revenue growth and an even more impressive 18.9% increase in earnings, surpassing the broader software industry’s performance. This growth trajectory is complemented by a significant R&D commitment, ensuring continual innovation and competitiveness in a rapidly evolving tech landscape. Recent financials reveal yearly sales up to PLN 217.97 million from PLN 192.36 million, alongside net income rising to PLN 43.08 million from PLN 37.2 million, reflecting both operational efficiency and market acumen. Despite a recent dividend cut to PLN 0.60 per share, Shoper’s strategic investments in technology development position it well for sustained growth amidst shifting industry dynamics.

WSE:SHO Revenue and Expenses Breakdown as at Apr 2026 Key Takeaways Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OM:BONEX OM:SECT B and WSE:SHO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com